Clinical trial
Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular…
NCT00243789 · Cooperative International Neuromuscular Research Group, Other · Completed
Key facts
| NCT number | NCT00243789 |
|---|---|
| Title | Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy |
| Official title | A Double-Blinded Randomized Placebo Controlled Study of Daily Pentoxifylline as a Rescue Treatment in DMD |
| Lead sponsor | Cooperative International Neuromuscular Research Group, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Muscular Dystrophy, Duchenne |
| Intervention type | Drug |
| Interventions | Pentoxifylline |
| Enrollment | 64 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Oct 25, 2005 |
| Last update posted | Oct 27, 2011 |
| Countries | Argentina, Australia, Canada, Israel, Italy, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: